CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 34 enrolled
Drug / intervention
etafilcon a Test 1 +3 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03782571
NCT03782571N/ACompleted
CompareCT.gov

Influence of Lens Design on Particulate Exchange in the Post-lens Tear Film

Johnson & Johnson Vision Care, Inc.·interventional·Posted Dec 20, 2018·Updated May 12, 2020

In Brief

A clinical study evaluating etafilcon a Test 1, etafilcon A Test 2, and 2 other interventions for Visual Acuity. Completed, enrolled 34 participants across 1 site.

Detailed Summary

This is a 5-visit, controlled, bilateral, randomized, subject-masked, crossover (4 treatments x 4 period), non-dispensing study. Subjects will attend all study visits in their spectacle correction having not worn contact lenses on the day of the visit.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedDec 20, 2018
Enrollment StartNov 16, 2018
Primary CompletionMar 25, 2019
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 7.5 years ago

Interventions

etafilcon a Test 1device

1-DAY ACUVUE® MOIST

etafilcon A Test 2device

1-DAY ACUVUE® MOIST for ASTIGMATISM

etafilcon A Test 3device

1-DAY ACUVUE® MOIST MULTIFOCAL

Controlother

Bare Eye